Therefore, in CLL/SLL cases, the morphology and immunophenotype (CD20 +/dim, CD138-, MUM-1- detected by FC or IHC) are used to rule out plasma cells differentiation. The gene discussed is LXN; the disease is B-cell chronic lymphocytic leukemia.